Suita, Japan

Yoshihiro Oyamada

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sumitomo Pharma Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshihiro Oyamada. Retrieved from https://idiyas.com/inventor/yoshihiro-oyamada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yoshihiro Oyamada

Introduction

Yoshihiro Oyamada is a notable inventor based in Suita, Japan. He has made significant contributions to the field of medicinal preparations, particularly in the treatment of pain. His innovative work focuses on developing effective solutions for peripheral neuropathic pain.

Latest Patents

Yoshihiro Oyamada holds a patent for a medicinal preparation for external use. This invention pertains to a drug designed for the treatment and/or prevention of pain. Specifically, it contains as an active ingredient N-{[1-ethyl-6-(4-methylphenoxy)-1H-benzimidazol-2-yl]methyl}-L-alaninamide. This patent represents a significant advancement in pain management therapies.

Career Highlights

Oyamada is associated with Sumitomo Pharma Co., Ltd., where he has been instrumental in research and development. His work has contributed to the company's reputation for innovation in the pharmaceutical industry. With 1 patent to his name, he continues to push the boundaries of medicinal science.

Collaborations

Yoshihiro Oyamada has collaborated with esteemed colleagues such as Yoshinori Takada and Masayasu Tanaka. These partnerships have fostered a creative environment that encourages the development of groundbreaking medical solutions.

Conclusion

Yoshihiro Oyamada's contributions to medicinal preparations highlight his dedication to improving pain management. His innovative spirit and collaborative efforts continue to make a positive impact in the field of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…